Society Logo
ME/CFS Australia Ltd
Please click here to donate ME/CFS Australia (SA) Inc
 
 
Facebook
 
ME/CFS AUSTRALIA (SA) INC

Registered Charity 3104

Email:
sacfs@sacfs.asn.au

Mailing address:
PO Box 322,
Modbury North,
South Australia 5092

Office:
Suite 506,
North Terrace House,
19 North Terrace,
Hackney, SA, 5069


Phone:
1300 128 339

Office Hours:
Wednesdays, 11am-3pm

ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.

Disclaimer

ME/CFS Australia (SA) Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
PDF Application Form (PDF, 242KB)
Why become a member?

Hormonal Changes May Affect Fibromyalgia Onset

Wednesday 9 September 2015

 

From Fibromyalgia News Today:

 

Woman
 

Hormonal Changes May Affect Fibromyalgia Onset

By Maureen Newman
September 3rd, 2015

The disparity between men and women in developing fibromyalgia, where the female to male ratio is 7:1, causes many researchers to be suspicious of a link between sex hormones and chronic pain. Hormones may have a critical role in the onset, maintenance, and inhibition of pain. To determine if the clinical features and timing of hormonal changes have a relationship in a cohort of ethnically diverse individuals, a group of researchers from University of Miami Miller School of Medicine conducted a retrospective chart review of patients at the academic medical center in a period of one year.

“This retrospective chart review investigated differences in the prevalence of medical comorbidity between women with fibromyalgia and a control group women with chronic pain without fibromyalgia,” wrote Dr. Larry Brooks to describe the team’s article, “Assessing the Prevalence of Autoimmune, Endocrine, Gynecologic, and Psychiatric Comorbidities in an Ethnically Diverse Cohort of Female Fibromyalgia Patients: Does the Time from Hysterectomy Provide a Clue?“, which was published in Journal of Pain Research. “The specific aims were to compare the prevalence of autoimmune, psychiatric, endocrine, gynecologic pathology, the relationship between timing of gynecologic surgery, and pain onset.”

When reviewing patient charts, Dr. Brooks and three medical residents gathered data concerning diagnosis, year of pain onset, medical comorbidities, psychiatric comorbidities, surgical history, and date of hysterectomy, oophorectomy, or cystectomy. While date of pain onset and dates of surgical procedures were difficult to collect due to poor documentation, the researchers were able to adequately analyze 335 female patients for the study: 219 with fibromyalgia and 116 with chronic pain. They created a logistic regression model that incorporated the variables associated with fibromyalgia.

Autoimmune, total endocrine, and total gynecologic variables were significantly higher in the fibromyalgia group and were fit into the prediction model. Looking at gynecological features, the researchers noted that hysterectomy with oophorectomy, hysterectomy with oophorectomy and cystectomy, and total gynecologic surgeries were more likely to occur in the fibromyalgia patients. These surgeries preceded the onset of pain in 73.1% of patients.

“This study demonstrates that autoimmune, endocrine, and gynecologic pathologies occur more commonly in women with fibromyalgia than in those with chronic pain, which is consistent with findings in less ethnically diverse samples,” wrote the authors. Knowing that gynecologic surgery is associated with fibromyalgia in a wide variety of patients, gynecologists may wish to watch their patients for signs of fibromyalgia.

Maureen Newman is a researcher by trade, and brings her knowledge of the lab to BioNews Texas. Currently, she is serving as a PhD student at University of Rochester, and working towards a career of research in biomaterials for drug delivery and regenerative medicine. She is an integral part of Dr. Danielle Benoit’s laboratory, where she is investigating bone-homing therapeutics for osteoporosis treatment. She is a senior science and research columnist for BioNews Texas.

© BioNews Services 2015.
All rights reserved.

 

The above originally appeared here.

 


Arrow right

More Fibromyalgia News

 


 

blog comments powered by Disqus

Previous Previous Page